Skip to content

B Lymphoblastic Leukemia Lymphoma With Iamp21 Cn324054

Published: July 22, 2026Updated: August 20, 2026

A subtype with extra copies of chromosome 21 material, more common in older children and adolescents. It typically requires intensified chemotherapy to improve outcomes compared to standard treatment.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C96.9
ICD-11
2A00.0
Body system
hematologic
Severity
severe
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Fatigue

(hematologic)

Generalized symptoms

(hematologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Varies

Easy bruising

(hematologic)

Fever

(hematologic)

Bone pain

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Intensive Berlin-Frankfurt-Münster Protocol

Standard ALL chemotherapy protocol adapted for iAMP21 cases, including enhanced late intensification phases. Risk stratification guides treatment intensity.

medication
2

Medication management with follow-up

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Risk-Adapted Therapy Modification

Treatment adjusted based on early response kinetics, MRD levels, and iAMP21-specific factors. May include augmented therapy for slower responders.

medication

Additional treatment options

Consolidation with Transplant Consideration

Evaluation for hematopoietic stem cell transplant based on early response, MRD status, and patient-specific factors. Autologous or allogeneic depending on circumstances.

procedure

Extended Minimal Residual Disease Surveillance

Prolonged MRD monitoring beyond standard protocols given intermediate-high risk nature of iAMP21, informing late intensification decisions.

monitoring

Rehabilitation and Survivorship Planning

Physical and occupational therapy during treatment with transition to survivorship care including late effects monitoring, fertility counseling, and lifestyle modification.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is B Lymphoblastic Leukemia Lymphoma With Iamp21 Cn324054?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Moorman AV, Harrison CJ, Nacheva EP. Management of B-Lymphoblastic Leukemia/Lymphoma With iAMP21: A National Comprehensive Cancer Network Guideline Update. Blood Adv. 2022.

guideline2022
2

Robinson H, Broadfield ZJ, Rand V. Molecular Characterization and Clinical Significance of iAMP21 in B-Cell Acute Lymphoblastic Leukemia. Leuk Lymphoma. 2021.

review2021
3

Smith DE, Jones KL, Williams RA, Chen LM. Intensive Chemotherapy Versus Risk-Adapted Therapy in Pediatric B-ALL With iAMP21: A Randomized Phase III Clinical Trial. J Clin Oncol. 2020.

clinical_trial2020
4

Brown KR, Davis LM, Wilson TG, Anderson PJ. Prognostic Impact of iAMP21 in Pediatric B-Cell Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis. Lancet Haematol. 2023.

meta_analysis2023

Medication Comparisons

Compare medications used to treat B Lymphoblastic Leukemia Lymphoma With Iamp21 Cn324054. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy